Literature DB >> 2957965

Plasmin induces acantholysis in skin organ cultures.

T Hunziker, J D Vassalli.   

Abstract

Addition of human plasminogen to three different pemphigus plasma samples showed a synergistic effect on acantholysis in the skin organ culture model. Human plasmin itself, without addition of pemphigus plasma, induced typical acantholytic changes in the skin explants, causing different types of acantholysis in a dose- and time-dependent manner: in the presence of 3 CU plasmin per ml culture medium, focal suprabasilar acantholysis of pemphigus vulgaris type could be detected after 72 h incubation, whereas 15 CU/ml caused extended acantholysis of pemphigus foliaceus type in the upper epidermal layers after 24 h, and extended acantholysis of benign chronic pemphigus (Hailey-Hailey disease) type comprising all layers of the epidermis after 48 h incubation. Plasminogen activator levels (Mr 55,000 urokinase type) in tissue extracts of skin explants and in culture media were reduced after 24 and 48 h incubation with pemphigus IgG as compared to control experiments with normal human IgG; this probably resulted from urokinase inactivation by reaction with inhibitors. These results lend support to the hypothesis proposed by Hashimoto et al. in 1983 that the plasminogen activator-plasmin system could play an essential role in the protease mechanisms of pemphigus acantholysis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957965     DOI: 10.1007/bf00431228

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  19 in total

1.  Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis.

Authors:  G J Anhalt; H P Patel; R S Labib; L A Diaz; D Proud
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

2.  Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase.

Authors:  R M Farb; R Dykes; G S Lazarus
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

Review 3.  Pathogenesis of autoimmunity in pemphigus.

Authors:  K H Singer; K Hashimoto; P J Jensen; S Morioka; G S Lazarus
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

4.  Production of three plasminogen activators and an inhibitor in keratinocyte cultures.

Authors:  H Birkedal-Hansen; R E Taylor
Journal:  Biochim Biophys Acta       Date:  1983-04-20

5.  A proenzyme form of human urokinase.

Authors:  T C Wun; L Ossowski; E Reich
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

Review 6.  Diagnosis of bullous disease and studies in the pathogenesis of blister formation using immunopathological techniques.

Authors:  A Razzaque Ahmed
Journal:  J Cutan Pathol       Date:  1984-08       Impact factor: 1.587

7.  Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies.

Authors:  J R Stanley; L Koulu; C Thivolet
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

8.  Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.

Authors:  M Philips; A G Juul; S Thorsen
Journal:  Biochim Biophys Acta       Date:  1984-11-06

9.  Plasminogen activator released as inactive proenzyme from murine cells transformed by sarcoma virus.

Authors:  L Skriver; L S Nielsen; R Stephens; K Danø
Journal:  Eur J Biochem       Date:  1982-05-17

10.  Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation.

Authors:  K Hashimoto; K M Shafran; P S Webber; G S Lazarus; K H Singer
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  3 in total

1.  Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann.

Authors:  J Reinartz; H Näher; H Mai; M D Kramer
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

2.  Proteinase inhibitors and pemphigus vulgaris. An in vitro and in vivo study.

Authors:  H Dobrev; L Popova; D Vlashev
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

3.  Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpression.

Authors:  Isabelle Bolon; Hong-Ming Zhou; Yves Charron; Annelise Wohlwend; Jean-Dominique Vassalli
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.